Scout Investments’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$9.98M Sell
188,394
-30,487
-14% -$1.75M 0.26% 127
2024
Q2
$11.5M Sell
218,881
-26,980
-11% -$1.18M 0.31% 125
2024
Q1
$10.2M Sell
245,861
-15,622
-6% -$586K 0.25% 135
2023
Q4
$9.66M Sell
261,483
-4,095
-2% -$154K 0.24% 135
2023
Q3
$10M Sell
265,578
-7,720
-3% -$316K 0.23% 123
2023
Q2
$12M Sell
273,298
-8,149
-3% -$278K 0.24% 127
2023
Q1
$10.7M Sell
281,447
-3,297
-1% -$155K 0.22% 127
2022
Q4
$16.2M Sell
284,744
-14,784
-5% -$757K 0.33% 97
2022
Q3
$11.8M Buy
299,528
+94
+0% +$4.16K 0.25% 123
2022
Q2
$13.2M Buy
299,434
+7,914
+3% +$342K 0.26% 112
2022
Q1
$11.6M Sell
291,520
-379
-0.1% -$13.5K 0.19% 134
2021
Q4
$11.7M Sell
291,899
-6,555
-2% -$245K 0.17% 166
2021
Q3
$12.1M Sell
298,454
-12,238
-4% -$512K 0.18% 170
2021
Q2
$14.1M Sell
310,692
-26,062
-8% -$1.15M 0.21% 150
2021
Q1
$14M Buy
336,754
+34,251
+11% +$1.56M 0.21% 157
2020
Q4
$12.9M Buy
302,503
+8,600
+3% +$309K 0.24% 161
2020
Q3
$7.72M Buy
293,903
+54,709
+23% +$1.52M 0.17% 197
2020
Q2
$6.41M Buy
+239,194
New +$5.4M 0.15% 204

Other funds holding HALO

Scout Investments's HALO Position: Q3 2024 in Review

Scout Investments reduced its Halozyme (HALO) stake by 14% in Q3 2024, selling an estimated $1.75M and leaving 188,394 shares worth $9.98M. The position accounts for 0.26% of the portfolio, ranked #127.

Scout Investments first reported a position in HALO in Q2 2020 and has held it in 18 quarters since. The position peaked at $16.2M in Q4 2022. 508 funds tracked by Wall St. Rank hold HALO as of Q3 2024.

  • Scout Investments held 188,394 shares of Halozyme worth $9.98M as of Q3 2024.
  • Scout Investments sold 30,487 Halozyme shares in Q3 2024, an estimated $1.75M.
  • Halozyme made up 0.26% of Scout Investments's portfolio in Q3 2024, its #127 holding.
  • Scout Investments first reported a position in Halozyme in Q2 2020 and has held it in 18 quarters since.
  • Scout Investments's Halozyme position peaked at $16.2M in Q4 2022.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q3 2024.

Based on Scout Investments's 13F filing for Q3 2024, filed 12 Nov 2024.